Literature DB >> 12509856

Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.

Michael Bunse1, Nana Bit-Avragim, Axel Riefflin, Andreas Perrot, Oliver Schmidt, Friedmar R Kreuz, Rainer Dietz, Wulf-Ingo Jung, Karl Josef Osterziel.   

Abstract

Friedreich's ataxia is a neurodegenerative disease frequently associated with hypertrophic cardiomyopathy. We have determined mitochondrial ATP, phosphocreatine, and intracellular inorganic phosphate levels by 31P nuclear magnetic resonance spectroscopy in the heart of 11 Friedreich's ataxia patients and 11 healthy controls. For the first time, to our knowledge, we showed a significant correlation between the extent of myocardial energy deficiency and the degree of myocardial hypertrophy. When combining our results with previous works on Friedreich's ataxia, these novel findings suggest that energy metabolism is most likely the cause and hypertrophy the effect in Friedreich's ataxia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509856     DOI: 10.1002/ana.10419

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  15 in total

Review 1.  Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.

Authors:  Arnulf H Koeppen
Journal:  J Neurol Sci       Date:  2011-04-15       Impact factor: 3.181

2.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

Review 3.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

4.  The Heart in Friedreich's Ataxia: Basic Findings and Clinical Implications.

Authors:  R Mark Payne
Journal:  Prog Pediatr Cardiol       Date:  2011-05

Review 5.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

Review 6.  Cardiomyopathy in Friedreich ataxia: clinical findings and research.

Authors:  R Mark Payne; Gregory R Wagner
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

7.  Cross-sectional analysis of electrocardiograms in a large heterogeneous cohort of Friedreich ataxia subjects.

Authors:  Kimberly A Schadt; Lisa S Friedman; Sean R Regner; George E Mark; David R Lynch; Kimberly Y Lin
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

8.  Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells.

Authors:  Yee-Ki Lee; Philip Wing-Lok Ho; Revital Schick; Yee-Man Lau; Wing-Hon Lai; Ting Zhou; Yanhua Li; Kwong-Man Ng; Shu-Leung Ho; Miguel Angel Esteban; Ofer Binah; Hung-Fat Tse; Chung-Wah Siu
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

9.  Phosphorus-31 two-dimensional chemical shift imaging in the myocardium of patients with late onset of Friedreich ataxia.

Authors:  Christian Wolf; Sylvia Boesch; Bernhard Metzler; Helga Weirich-Schwaiger; Thomas Trieb; Michael F H Schocke
Journal:  Mol Imaging Biol       Date:  2007-11-14       Impact factor: 3.488

Review 10.  Cardiac metabolism in hypertrophy and heart failure: implications for therapy.

Authors:  N Siddiqi; S Singh; R Beadle; D Dawson; M Frenneaux
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.